S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

$12.18
-0.23 (-1.85%)
(As of 04/17/2024 ET)
Today's Range
$11.84
$12.59
50-Day Range
$6.25
$20.25
52-Week Range
$4.94
$20.52
Volume
865,897 shs
Average Volume
1.59 million shs
Market Capitalization
$586.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50

Cardlytics MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
27.3% Upside
$15.50 Price Target
Short Interest
Bearish
12.35% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.54mentions of Cardlytics in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$8.96 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.66 out of 5 stars

Business Services Sector

75th out of 297 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

15th out of 59 stocks

CDLX stock logo

About Cardlytics Stock (NASDAQ:CDLX)

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CDLX Stock Price History

CDLX Stock News Headlines

AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Cardlytics, Inc. (NASDAQ:CDLX) Short Interest Up 32.8% in March
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
Craig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)
Why Cardlytics (CDLX) Stock Is Down 30%
Why Cardlytics Stock Tanked by 33% Today
CDLX May 2024 12.500 call
CDLX Jul 2024 17.500 put
Cardlytics Inc.
See More Headlines
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/17/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:CDLX
Fax
N/A
Employees
434
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$15.50
High Stock Price Target
$18.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+27.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-134,700,000.00
Pretax Margin
-43.56%

Debt

Sales & Book Value

Annual Sales
$309.20 million
Cash Flow
$1.16 per share
Book Value
$3.43 per share

Miscellaneous

Free Float
43,765,000
Market Cap
$586.71 million
Optionable
Optionable
Beta
1.44

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Karim Temsamani (Age 50)
    CEO & Director
    Comp: $424.02k
  • Mr. Nick Lynton
    Chief Legal & Privacy Officer and Secretary
  • Ms. Alexis DeSieno
    Chief Financial Officer
  • Mr. Amit Gupta
    COO & GM of Bridg
  • Mr. Peter Chan
    Chief Technology Officer
  • Mr. Peter Davies
    Head of Sales Strategy & Operations
  • Ms. Carson Napps
    Head of People
  • Mr. Jose Singer
    Chief Product Officer
  • Ms. Evelyne Forester
    Chief Business Officer

CDLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardlytics stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CDLX shares.
View CDLX analyst ratings
or view top-rated stocks.

What is Cardlytics' stock price target for 2024?

4 brokers have issued 1-year price objectives for Cardlytics' stock. Their CDLX share price targets range from $9.00 to $18.00. On average, they predict the company's stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for CDLX
or view top-rated stocks among Wall Street analysts.

How have CDLX shares performed in 2024?

Cardlytics' stock was trading at $9.21 at the beginning of the year. Since then, CDLX shares have increased by 32.2% and is now trading at $12.18.
View the best growth stocks for 2024 here
.

Are investors shorting Cardlytics?

Cardlytics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,950,000 shares, an increase of 32.8% from the March 15th total of 4,480,000 shares. Based on an average daily trading volume, of 1,680,000 shares, the short-interest ratio is presently 3.5 days.
View Cardlytics' Short Interest
.

When is Cardlytics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CDLX earnings forecast
.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.14) EPS for the quarter. The company earned $89.17 million during the quarter. Cardlytics had a negative net margin of 43.56% and a negative trailing twelve-month return on equity of 25.38%.

What ETF holds Cardlytics' stock?

Invesco Dorsey Wright Technology Momentum ETF holds 380,072 shares of CDLX stock, representing 1.38% of its portfolio.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million.

What is Lynne Laube's approval rating as Cardlytics' CEO?

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.24%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes.
View institutional ownership trends
.

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cardlytics have any subsidiaries?
The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.
Read More
This page (NASDAQ:CDLX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners